b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">29462500</PMID>\n        <DateCompleted>\n            <Year>2018</Year>\n            <Month>03</Month>\n            <Day>22</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>04</Month>\n            <Day>16</Day>\n        </DateRevised>\n        <Article PubModel="Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1469-493X</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>2</Volume>\n                    <PubDate>\n                        <Year>2018</Year>\n                        <Month>02</Month>\n                        <Day>20</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>The Cochrane database of systematic reviews</Title>\n                <ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Antifibrinolytic drugs for treating primary postpartum haemorrhage.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>CD012964</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1002/14651858.CD012964</ELocationID>\n            <Abstract>\n                <AbstractText Label="BACKGROUND">Postpartum haemorrhage (PPH) - heaving bleeding within the first 24 hours after giving birth - is one of the main causes of death of women after childbirth. Antifibrinolytics, primarily tranexamic acid (TXA), have been shown to reduce bleeding in surgery and safely reduces mortality in trauma patients with bleeding without increasing the risk of adverse events.An earlier Cochrane review on treatments for primary PPH covered all the various available treatments - that review has now been split by types of treatment. This new review concentrates only on the use of antifibrinolytic drugs for treating primary PPH.</AbstractText>\n                <AbstractText Label="OBJECTIVES">To determine the effectiveness and safety of antifibrinolytic drugs for treating primary PPH.</AbstractText>\n                <AbstractText Label="SEARCH METHODS">We searched Cochrane Pregnancy and Childbirth\'s Trials Register, ClinicalTrials.gov, the WHO International Clinical Trials Registry Platform (ICTRP) (28 May 2017) and reference lists of retrieved studies.</AbstractText>\n                <AbstractText Label="SELECTION CRITERIA">Randomised controlled trials (RCTs), including cluster-randomised trials of antifibrinolytic drugs (aprotinin, TXA, epsilon-aminocaproic acid (EACA) and aminomethylbenzoic acid, administered by whatever route) for primary PPH in women.Participants in the trials were women after birth following a pregnancy of at least 24 weeks\' gestation with a diagnosis of PPH, regardless of mode of birth (vaginal or caesarean section) or other aspects of third stage management.We have not included quasi-randomised trials, or cross-over studies. Studies reported as abstracts have not been included if there was insufficient information to allow assessment of risk of bias.In this review we only identified studies looking at TXA.</AbstractText>\n                <AbstractText Label="DATA COLLECTION AND ANALYSIS">Two review authors independently extracted data from each study using an agreed form. We entered data into Review Manager software and checked for accuracy.For key review outcomes, we rated the quality of the evidence as \'high\', \'moderate\', \'low\' or \'very low\' according to the GRADE approach.</AbstractText>\n                <AbstractText Label="MAIN RESULTS">Three trials (20,412 women) met our inclusion criteria. Two trials (20,212 women) compared intravenous (IV) TXA with placebo or standard care and were conducted in acute hospital settings (labour ward, emergency department) (in high-, middle- and low-income countries).One other trial (involving 200 women) was conducted in Iran and compared IV TXA with rectal misoprostol, but did not report on any of this review\'s primary or GRADE outcomes. There were no trials that assessed EACA, aprotinin or aminomethylbenzoic acid.Standard care plus IV TXA for the treatment of primary PPH compared with placebo or standard care aloneTwo trials (20,212 women) assessed the effect of TXA for the treatment of primary PPH compared with placebo or standard care alone. The larger of these (The WOMAN trial) contributed over 99% of the data and was assessed as being at low risk of bias. The quality of the evidence varied for different outcomes, Overall, evidence was mainly graded as moderate to high quality.The data show that IV TXA reduces the risk of maternal death due to bleeding (risk ratio (RR) 0.81, 95% confidence interval (CI) 0.65 to 1.00; two trials, 20,172 women; quality of evidence: moderate). The quality of evidence was rated as moderate due to imprecision of effect estimate. The effect was more evident in women given treatment between one and three hours after giving birth with no apparent reduction when given after three hours (&lt; one hour = RR 0.80, 95% CI 0.55 to 1.16; one to three hours = RR 0.60, 95% CI 0.41 to 0.88; &gt; three hours = RR 1.07, 95% 0.76 to 1.51; test for subgroup differences: Chi\xc2\xb2 = 4.90, df = 2 (P = 0.09), I\xc2\xb2 = 59.2%). There was no heterogeneity in the effect by mode of birth (test for subgroup differences: Chi\xc2\xb2 = 0.01, df = 1 (P = 0.91), I\xc2\xb2 = 0%). There were fewer deaths from all causes in women receiving TXA, although the 95% CI for the effect estimate crosses the line of no effect (RR 0.88, 95% CI 0.74 to 1.05; two trials, 20,172 women, quality of evidence: moderate). Results from one trial with 151 women suggest that blood loss of \xe2\x89\xa5 500 mL after randomisation may be reduced (RR 0.50, 95% CI 0.27 to 0.93; one trial, 151 women; quality of evidence: low). TXA did not reduce the risk of serious maternal morbidity (RR 0.99, 95% CI 0.83 to 1.19; one trial, 20,015 women; quality of evidence: high), hysterectomy to control bleeding (RR 0.95, 95% CI 0.81 to 1.12; one trial, 20,017 women; quality of evidence: high) receipt of blood transfusion (any) (RR 1.00, 95% CI 0.97 to 1.03; two trials, 20,167 women; quality of evidence: moderate) or maternal vascular occlusive events (any), although results were imprecise for this latter outcome (RR 0.88, 95% CI 0.54 to 1.43; one trial, 20,018 women; quality of evidence: moderate). There was an increase in the use of brace sutures in the TXA group (RR 1.19, 95% CI 1.01, 1.41) and a reduction in the need for laparotomy for bleeding (RR 0.64, 95% CI 0.49, 0.85).</AbstractText>\n                <AbstractText Label="AUTHORS\' CONCLUSIONS">TXA when administered intravenously reduces mortality due to bleeding in women with primary PPH, irrespective of mode of birth, and without increasing the risk of thromboembolic events. Taken together with the reliable evidence of the effect of TXA in trauma patients, the evidence suggests that TXA is effective if given as early as possible.Facilities for IV administration may not be available in non-hospital settings therefore, alternative routes to IV administration need to be investigated.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Shakur</LastName>\n                    <ForeName>Haleema</ForeName>\n                    <Initials>H</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Clinical Trials Unit, London School of Hygiene &amp; Tropical Medicine, Keppel Street, London, UK, WC1E 7HT.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Beaumont</LastName>\n                    <ForeName>Danielle</ForeName>\n                    <Initials>D</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Pavord</LastName>\n                    <ForeName>Sue</ForeName>\n                    <Initials>S</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Gayet-Ageron</LastName>\n                    <ForeName>Angele</ForeName>\n                    <Initials>A</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ker</LastName>\n                    <ForeName>Katharine</ForeName>\n                    <Initials>K</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Mousa</LastName>\n                    <ForeName>Hatem A</ForeName>\n                    <Initials>HA</Initials>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D013485">Research Support, Non-U.S. Gov\'t</PublicationType>\n                <PublicationType UI="D016454">Review</PublicationType>\n                <PublicationType UI="D000078182">Systematic Review</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>02</Month>\n                <Day>20</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>Cochrane Database Syst Rev</MedlineTA>\n            <NlmUniqueID>100909747</NlmUniqueID>\n            <ISSNLinking>1361-6137</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000933">Antifibrinolytic Agents</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0E43V0BB57</RegistryNumber>\n                <NameOfSubstance UI="D016595">Misoprostol</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>6T84R30KC1</RegistryNumber>\n                <NameOfSubstance UI="D014148">Tranexamic Acid</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000933" MajorTopicYN="N">Antifibrinolytic Agents</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002423" MajorTopicYN="N">Cause of Death</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008428" MajorTopicYN="N">Maternal Mortality</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016595" MajorTopicYN="N">Misoprostol</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006473" MajorTopicYN="N">Postpartum Hemorrhage</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n                <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D014148" MajorTopicYN="N">Tranexamic Acid</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>2</Month>\n                <Day>21</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2018</Year>\n                <Month>3</Month>\n                <Day>23</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>2</Month>\n                <Day>21</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>epublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29462500</ArticleId>\n            <ArticleId IdType="doi">10.1002/14651858.CD012964</ArticleId>\n            <ArticleId IdType="pmc">PMC6491317</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Obstet Gynecol Clin North Am. 1999 Sep;26(3):419-34, vii</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10472062</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Baillieres Best Pract Res Clin Obstet Gynaecol. 2000 Feb;14(1):1-18</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10789257</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet. 2006 Apr 1;367(9516):1066-1074</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16581405</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet. 2006 Sep 30;368(9542):1189-200</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17011946</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>BJOG. 2007 Nov;114(11):1380-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17877772</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Best Pract Res Clin Obstet Gynaecol. 2008 Dec;22(6):999-1012</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18819848</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>BJOG. 2009 Jul;116(8):1097-102</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19459866</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Trials. 2010 Apr 16;11:40</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20398351</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet. 2010 Jul 3;376(9734):23-32</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20554319</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Obstet Gynecol. 1990 May;162(5):1158-63</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">2140236</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cochrane Database Syst Rev. 2011 Mar 16;(3):CD001886</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21412876</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Crit Care. 2011;15(2):R117</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21496253</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Acta Obstet Gynecol Scand. 2012 May;91(5):529-37</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22229782</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>BMJ. 2012 May 17;344:e3054</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22611164</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Trials. 2012 Jul 17;13:110</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22805300</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cochrane Database Syst Rev. 2013 Jan 31;(1):CD010245</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23440847</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Health Technol Assess. 2013 Mar;17(10):1-79</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23477634</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Surg. 2013 Sep;100(10):1271-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23839785</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 1987 Feb;69(2):460-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">2432970</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cochrane Database Syst Rev. 2014 Feb 13;(2):CD003249</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24523225</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Obstet Gynecol. 2014 May;123(5):987-96</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24785851</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet Glob Health. 2014 Jun;2(6):e323-33</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25103301</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Niger Med J. 2014 Jul;55(4):348-53</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25114373</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Anaesth. 2015 Apr;114(4):623-33</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25586727</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Thromb Haemost. 2015 Apr;13(4):520-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25594352</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Dan Med J. 2015 Apr;62(4):B5055</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25872542</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Trials. 2015 Apr 17;16:169</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25906770</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cochrane Database Syst Rev. 2015 May 09;(5):CD004896</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25956410</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cochrane Database Syst Rev. 2015 Jun 16;(6):CD007872</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26079202</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet. 2016 Jan 30;387(10017):462-74</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26584737</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Anaesth Crit Care Pain Med. 2016 Aug;35(4):293-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27004917</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Anaesth. 2016 May;116(5):641-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27106967</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Trials. 2016 May 17;17(1):249</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27188698</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cochrane Database Syst Rev. 2016 Sep 19;9:CD006883</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27643712</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Wellcome Open Res. 2016 Dec 15;1:29</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28090594</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Wellcome Open Res. 2016 Dec 16;1:31</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28317031</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet. 2017 May 27;389(10084):2105-2116</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28456509</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet. 2018 Jan 13;391(10116):125-132</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29126600</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Haemostasis. 1982;11(4):235-41</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">6982199</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Pathol Suppl (R Coll Pathol). 1980;14:41-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">7000846</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Thorac Surg. 1993 Apr;55(4):1033-41</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">7682054</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'